Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-1994 | 06-1994 | 03-1994 | 12-1993 | 09-1993 | |
| Sales | 543,420 | 535,075 | 468,683 | 493,005 | 462,146 |
| Gross Profit | 543,420 | 535,075 | 468,683 | 493,005 | 462,146 |
| Operating Income | 543,420 | 535,075 | 468,683 | 493,005 | 462,146 |
| Pre-tax Income | 543,420 | 535,075 | 468,683 | 493,005 | 462,146 |
| Net Income Continuous | 61,939 | 43,540 | 40,365 | 63,304 | 60,345 |
| Net Income | $61,939 | $43,540 | $40,365 | $63,304 | $60,345 |
| EPS Basic Total Ops | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| EPS Basic Continuous Ops | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| EPS Diluted Total Ops | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| EPS Diluted Continuous Ops | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| EBITDA(a) | $543,420 | $535,075 | $468,683 | $493,005 | $462,146 |